5 December 2017Europe

Horizon Discovery expands CRISPR licence with ERS Genomics

UK-based genomics company Horizon Discovery has expanded its licence coverage for use of the CRISPR gene-editing technology.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Horizon partners with big pharma company on CRISPR

29 August 2018 UK-based Horizon Discovery has entered into a CRISPR collaboration with an unnamed big pharma company.

EPO grants second CRISPR patent to ERS Genomics

7 March 2018 The European Patent Office has granted a second CRISPR/Cas9 patent to a specialist genomics company, one month after revoking the Broad Institute of Harvard and MIT’s patent relating to the technology.

CRISPR in Europe: the patent landscape for 2018

30 November 2017 The Broad Institute of MIT and Harvard may lose a substantial number of European patent claims covering CRISPR/Cas9, but it has at least one trump card to play before we get to that stage, one European patent attorney has told LSIPR.

More on this story

Horizon partners with big pharma company on CRISPR

29 August 2018 UK-based Horizon Discovery has entered into a CRISPR collaboration with an unnamed big pharma company.

EPO grants second CRISPR patent to ERS Genomics

7 March 2018 The European Patent Office has granted a second CRISPR/Cas9 patent to a specialist genomics company, one month after revoking the Broad Institute of Harvard and MIT’s patent relating to the technology.

CRISPR in Europe: the patent landscape for 2018

30 November 2017 The Broad Institute of MIT and Harvard may lose a substantial number of European patent claims covering CRISPR/Cas9, but it has at least one trump card to play before we get to that stage, one European patent attorney has told LSIPR.

More on this story

Horizon partners with big pharma company on CRISPR

29 August 2018 UK-based Horizon Discovery has entered into a CRISPR collaboration with an unnamed big pharma company.

EPO grants second CRISPR patent to ERS Genomics

7 March 2018 The European Patent Office has granted a second CRISPR/Cas9 patent to a specialist genomics company, one month after revoking the Broad Institute of Harvard and MIT’s patent relating to the technology.

CRISPR in Europe: the patent landscape for 2018

30 November 2017 The Broad Institute of MIT and Harvard may lose a substantial number of European patent claims covering CRISPR/Cas9, but it has at least one trump card to play before we get to that stage, one European patent attorney has told LSIPR.

More features

Lord Justice Birss to become chancellor of the High Court

Bankruptcy judge approves $305m sale of genetics testing company

Sanofi successfully challenges rare disease patent in Europe

Bayer appoints new head of IP

WATCH: Policy direction—where are we now?

Broad Institute wins appeal to restore CRISPR patent in Europe

BMS faces fresh lawsuit over alleged cancer drug monopoly

WATCH: Synergy in science—navigating the landscape of pharmaceutical collaborations